Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
ATP + 1,2-diacylglycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
-
-
-
?
ATP + 1,2-dioleoylglycerol
ADP + 1,2-dioleoylglycerol 3-phospate
modeling of lipid substrate binding, involving residues Arg9, Ser17, Ser98 and Glu69, overview
-
-
?
1,2-dipalmitoyl-sn-glycerol + GTP
GDP + 1,2-dipalmitoyl-sn-glycerol 3-phosphate
-
-
-
-
?
2'-deoxy-ATP + sn-1,2-dihexanoylglycerol
2'-deoxy-ADP + sn-1,2-dihexanoylglycerol 3-phosphate
-
-
-
-
?
ADP + sn-1,2-dihexanoylglycerol
AMP + sn-1,2-dihexanoylglycerol 3-phosphate
-
MgADP- is a very poor phosphoryl donor
-
-
?
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
ATP + 1,2-diacylglycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
-
-
i.e. phosphatidic acid
-
r
ATP + 1,2-dihexanoylglycerol
ADP + 1,2-dihexanoylglycerol 3-phosphate
-
-
-
-
?
ATP + ceramide
ADP + ceramide 3-phosphate
-
-
-
-
?
ATP + sn-1,2-dihexanoylglycerol
ADP + sn-1,2-dihexanoylglycerol 3-phosphate
-
-
-
-
?
ATP + sn-1,2-dioctanoylglycerol
ADP + sn-1,2-dioctanoylglycerol 3-phosphate
-
-
-
-
?
ATP + sn-1,2-dioleoylglycerol
ADP + sn-1,2-dioleoylglycerol 3-phosphate
-
-
-
-
?
GTP + sn-1,2-dihexanoylglycerol
GDP + sn-1,2-dihexanoylglycerol 3-phosphate
-
-
-
-
?
ITP + sn-1,2-dihexanoylglycerol
IDP + sn-1,2-dihexanoylglycerol 3-phosphate
-
-
-
-
?
additional information
?
-
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
-
-
-
?
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
enzyme DgkA primarily recognizes diacylglycerol in the glycerol backbone and ester linkages but not the fatty acyl group
-
-
?
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
-
-
-
-
?
ATP + 1,2-diacyl-sn-glycerol
ADP + 1,2-diacyl-sn-glycerol 3-phosphate
-
the enzyme functions to recycle diacylglycerol which is generated largely as a by-product of membrane-derived oligosaccharide biosynthesis
-
-
?
additional information
?
-
DgkA also has ATPase activity which is about 25% of its kinase activity
-
-
?
additional information
?
-
-
sn-1,3-dioleoylglycerol is not a substrate
-
-
?
additional information
?
-
-
no activity with ficaprenol
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,3-dioleoylglycerol
-
activates
1-monooleoylglycerol
-
activates
1-O-alkylphosphatidylcholine
-
half-maximal activation at 21.9 mol%
1-palmitoyl-2-oleoylglycerophosphocholine
-
activates
bis-phosphatidic acid
-
half-maximal activation at 3.9 mol%
-
cholesterol 3-sulfate
-
activates
di-O-hexadecylphosphatidylcholine
-
half-maximal activation at 13.5 mol%
diacylglycerol 3-phosphate
-
the enzyme apoprotein is attributed to a novel feedback activation involving diacylglycerol 3-phosphate
dilauroyl-N,N-dimethylglycerophosphoethanolamine
-
activates
dilauroyl-N-methylglycerophosphoethanolamine
-
activates
dilauroylglycerophosphocholine
-
activates
dilauroylglycerophosphoethanolamine
-
activates
dilauroylphosphatidylcholine
-
half-maximal activation at 11.9 mol%
dimethylmyristamide
-
activates
dioleoyl ethylene glycol
-
activates
dioleoylphosphatidylcholine
-
half-maximal activation at 10.4 mol%
dioleoylphosphatidylglycerol
-
half-maximal activation at 6.3 mol%
dipalmitoylphosphatidic acid
-
activates only in presence of Triton X-100
hexadecyl phosphorylcholine
-
half-maximal activation at 17.3 mol%
hexadecylphosphorylcholine
-
activates
lauryl maltoside
-
activates in presence of 11 mM Triton X-100
Lipid
-
purified enzyme is completely inactive unless a lipid is added to the assay buffer containing Triton X-100
lysophosphatidylethanolamine
-
activates
methyl myristate
-
activates
myristoylcholine chloride
-
activates
myristyl acetate
-
activates
n-hexyl beta-D-glucoside
-
activates in presence of 11 mM Triton X-100
nitrododecane
-
activates
octyl acetate
-
activates
octyl beta-glucoside
-
activates in presence of 11 mM Triton X-100
oleic acid
-
activates only in presence of Triton X-100
oleoylcholine chloride
-
activates
palmitic acid
-
activates only in presence of Triton X-100
phosphatidic acid
-
activates only in presence of Triton X-100
phosphatidyl glycerol
-
good activator
phosphatidylcholine plasmalogen
-
half-maximal activation at 7.3 mol%
-
platelet-activating factor
-
half-maximal activation at 22.4 mol%
rac-1,2-dioleoylglycero-3-sulfate
-
half-maximal activation at 2.7 mol%
sn-1,2-dioleoylglycerol
-
activates
sn-1,3-dioleoylglycerol
-
activates
Sodium dodecyl sulfate
-
activates
sodium hexadecyl sulfate
-
half-maximal activation at 9.8 mol%
stearic acid
-
activates only in presence of Triton X-100
stearoyllysophosphatidylcholine
-
half-maximal activation at 15.8 mol%
cardiolipin
-
activates
cardiolipin
-
good activator
cardiolipin
-
mitochondrial, half-maximal activation at 2.3 mol%
phosphatidylcholine
-
-
phosphatidylcholine
-
activates
phosphatidylethanolamine
-
activates only in presence of Triton X-100
phosphatidylethanolamine
-
plus cardiolipin, activates
phosphatidylserine
-
-
phosphatidylserine
-
activates
phosphatidylserine
-
good activator
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4.2
2'-deoxy-ATP
-
pH 6.8, 30°C, reaction with sn-2,3-dihexanoylglycerol
1
ADP
-
about, pH 6.8, 30°C, reaction with sn-2,3-dihexanoylglycerol
0.23
ceramide
-
pH 6.6, 25°C
8.7
GTP
-
pH 6.8, 30°C, reaction with sn-2,3-dihexanoylglycerol
5.9
ITP
-
pH 6.8, 30°C, reaction with sn-2,3-dihexanoylglycerol
additional information
additional information
-
0.12
ATP
-
wild-type enzyme
0.12
ATP
-
ATP in form of MgATP2-
0.13
ATP
-
mutant C46A/C113A, pH 6.9, 25°C
0.14
ATP
-
mutant enzyme E76L
0.14
ATP
-
ATP in form of MgATP2-
0.33
ATP
-
mutant enzyme E69C
0.33
ATP
-
ATP in form of MgATP2-
0.34
ATP
-
wild-type, pH 6.9, 25°C
0.4
ATP
-
mutant C46A/C113A/Q33C, pH 6.9, 25°C
0.44
ATP
-
mutant enzyme N72S
0.44
ATP
-
ATP in form of MgATP2-
0.6
ATP
-
mutant C46A/C113A/E34C, pH 6.9, 25°C
0.91
ATP
-
mutant enzyme A14Q
0.91
ATP
-
ATP in form of MgATP2-
1
ATP
-
mutant C46A/C113A/A29C, pH 6.9, 25°C
1.3
ATP
-
mutant C46A/C113A/E28C, pH 6.9, 25°C
1.5
ATP
-
mutant enzyme K94V
1.5
ATP
-
ATP in form of MgATP2-
2.1
ATP
-
mutant enzyme D95N
2.1
ATP
-
mutant C46A/C113A/F31C, pH 6.9, 25°C
2.1
ATP
-
ATP in form of MgATP2-
2.6
ATP
-
pH 6.8, 30°C, reaction with sn-2,3-dihexanoylglycerol
3.3
ATP
-
mutant C46A/C113AA30C, pH 6.9, 25°C
4.8
ATP
-
mutant C46A/C113A/R32C, pH 6.9, 25°C
additional information
additional information
-
-
-
additional information
additional information
-
Km for dioleoylglycerol is 0.92 mol%
-
additional information
additional information
-
kinetics, recombinant wild-type and mutant enzymes
-
additional information
additional information
-
Km-value in mol% for wild-type 9.2, mutant C46A/C113A 4.9, mutant C46A/C113A/E28C 5.7, mutant C46A/C113A/A29C 7.4, mutant C46A/C113AA30C 27.2, mutant C46A/C113A/F31C 17.2, mutant C46A/C113A/R32C 12.9, mutant C46A/C113A/Q33C 12.1, mutant C46A/C113A/E34C 13.7
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
physiological function
diacylglycerol kinase catalyzes the ATP-dependent phosphorylation of diacylglycerol to phosphatidic acid for use in shuttling water-soluble components to membrane-derived oligosaccharide and lipopolysaccharide in the cell envelope of Gram-negative bacteria
evolution
as the smallest kinase known, it shares no sequence homology with conventional kinases and possesses a distinct trimer structure. The phosphorylation reaction of diacylglycerol kinase features the same phosphoryl transfer mechanism as other kinases, despite its unique structural properties. DgkA appears to be an evolutionarily optimized enzyme and its chemical reaction rate approaches the substrate diffusion-controlled rate limit
evolution
DgkA is a unique kinase with a distinctive active site. It has no recognizable nucleotide sequence or structural binding motifs
additional information
1,2-dioctanoylglycerol is first docked into the active site of the crystal structure of DgkA, PDB ID 3ZE5, followed by construction of a ternary complex model by docking co-factor ATP and substrate 1,2-dioctanoylglycerol into the active site of DgkA. The complex of DgkA is optimized and equilibrated by molecular dynamics simulation in the lipid bilayer. The phosphotransfer reaction catalyzed by DgkA is then investigated through the hybrid density functional theory method B3LYP. Important role of the surface helix in the active site formation
additional information
Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76 both of which are essential, the gamma-phosphate of ATP is positioned for direct transfer to the primary hydroxyl of the lipid whose acyl chain is in the membrane, catalytic mechanism, overview. The putative catalytic site resides on the protein at the membrane/cytosol interface where the reactive moieties of the two substrates, with disparate polarities, come together for reaction. The ternary complex site, asBC, contains zinc-ACP and two lipid substrates. The gaamma-phosphate of the ATP analogue is positioned for direct transfer to the primary hydroxyl of the lipid whose acyl chain is in the membrane
additional information
-
Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76 both of which are essential, the gamma-phosphate of ATP is positioned for direct transfer to the primary hydroxyl of the lipid whose acyl chain is in the membrane, catalytic mechanism, overview. The putative catalytic site resides on the protein at the membrane/cytosol interface where the reactive moieties of the two substrates, with disparate polarities, come together for reaction. The ternary complex site, asBC, contains zinc-ACP and two lipid substrates. The gaamma-phosphate of the ATP analogue is positioned for direct transfer to the primary hydroxyl of the lipid whose acyl chain is in the membrane
additional information
DgkA catalyzes phosphoryl transfer expected to take place at a polar/apolar interface
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A100L
site-directed mutagenesis, inactive mutant
A13K
site-directed mutagenesis, the mutant shows slightly reduced activity compared to the wild-type enzyme
A13R
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
A30L
site-directed mutagenesis, the mutant shows 93% reduced activity compared to the wild-type enzyme
D80A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
D80E
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
D80N
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
D81A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
D81K
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
D95A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
D95E
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
D95N
site-directed mutagenesis, the mutant shows unaltered activity compared to the wild-type enzyme
E28A
site-directed mutagenesis, the mutation principally affects the binding of the Zn2+ ion, In the absence of the E28 side chain the zinc ions become purely coordinated by E76 and the ATP phosphates, the mutant shows highly reduced activity compared to the wild-type enzyme
E28D
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E28N
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E28Q
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E28R
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E34A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
E34D
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
E34Q
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
E69A
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
E69D
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
E69Q
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
E76D
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
E76Q
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
G20A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
G83P
site-directed mutagenesis, inactive mutant
G97P
site-directed mutagenesis, inactive mutant
K94A
K94 coordinates both alpha-phosphate and N7 of the adenine ring of ATP, the loss of the basic side-chain releases the adenine of ATP and the binding is lost, almost inactive mutant
K94M
K94 coordinates both alpha-phosphate and N7 of the adenine ring of ATP, the loss of the basic side-chain releases the adenine of ATP and the binding is lost, the mutant shows highly reduced activity compared to the wild-type enzyme
K94R
K94 coordinates both alpha-phosphate and N7 of the adenine ring of ATP, the loss of the basic side-chain releases the adenine of ATP and the binding is lost, almost inactive mutant
N72A
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
N72D
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
N72Q
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R32A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
R32K
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
R9A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R9E
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R9H
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R9K
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
S17A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
S73A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
S90P
site-directed mutagenesis, inactive mutant
S98A
site-directed mutagenesis, the mutant shows slightly reduced activity compared to the wild-type enzyme
Y86A
site-directed mutagenesis, the mutant shows unaltered activity compared to the wild-type enzyme
Y86F
site-directed mutagenesis, the mutant shows slightly reduced activity compared to the wild-type enzyme
A14Q
-
significantly impaired catalytic function, without evidence of gross structural alterations, subunit mixing experiments of mutant enzymes, subunit mixing experiments of mutant enzymes
C46A/C113A
-
mutant lacking all Cys residues. Activity is slightly higher than wild-type
C46A/C113A/A29C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 64% trimer formation compared to wild-type
C46A/C113A/A30C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 79% trimer formation compared to wild-type
C46A/C113A/E28C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 93% trimer formation compared to wild-type
C46A/C113A/Q33C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 77% trimer formation compared to wild-type
C46A/C113A/R32C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 63% trimer formation compared to wild-type
C46A/C113AE34C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 100% trimer formation compared to wild-type
C46A/C113AF31C
-
introduction of Cys residue at transmembrane helix 1 into mutant lacking the native Cys residues. Low activity mutant, 72% trimer formation compared to wild-type
D95N
-
significantly impaired catalytic function, without evidence of gross structural alterations. Km-value for MgATP2- raises 18fold, subunit mixing experiments of mutant enzymes
E69C
-
mutant enzyme has an altered structure even in SDS
E76L
-
significantly impaired catalytic function, without evidence of gross structural alterations, subunit mixing experiments of mutant enzymes
I110P
-
mutant enzyme can not be purified because its expression is toxic to the Escherichia coli host
I110R
-
mutant enzyme can not be purified because its expression is toxic to the Escherichia coli host
I110W
-
mutant is highly misfolding while at the same time being more stable than the wild-type protein
I110Y
-
mutant exhibits enhanced stability but folds with an efficiency similar to that of the wild type
K94L
-
significantly impaired catalytic function, without evidence of gross structural alterations. Km-value for MgATP2- raises 13fold, subunit mixing experiments of mutant enzymes
N72S
-
significantly impaired catalytic function, without evidence of gross structural alterations, subunit mixing experiments of mutant enzymes
W112L
-
site-directed mutagenesis, inactive mutant
W117L
-
site-directed mutagenesis, inactive mutant
W18L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W18L/W25L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W18L/W25L/W112L/W117L
-
site-directed mutagenesis, inactive mutant
W18L/W25L/W47L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W18L/W25L/W47L/W112L
-
site-directed mutagenesis, inactive mutant
W18L/W25L/W47L/W117L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W18L/W47L/W112L/W117L
-
site-directed mutagenesis, inactive mutant
W18L/W47L/W117L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W25L
-
site-directed mutagenesis, reduced activity compared to the wild-type enzyme
W25L/W47L/W112L/W117L
-
site-directed mutagenesis, inactive mutant
additional information
construction of a thermostabilized DELTA4 (4 changes relative to wild-type) form of DgkA using the DELTA7 structure, overview
E76A
site-directed mutagenesis, inactive mutant, Asn72 plays a key role in catalysis. Its side-chain amide bridges Glu69 and Glu76
E76A
site-directed mutagenesis, the mutation principally affects the binding of the Zn2+ ion
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Walsh, J.P.; Bell, R.M.
Diacylglycerol kinase from Escherichia coli
Methods Enzymol.
209
153-162
1992
Escherichia coli
brenda
Walsh, J.P.; Bell, R.M.
sn-1,2-Diacylglycerol kinase of Escherichia coli. Structural and kinetic analysis of the lipid cofactor dependence
J. Biol. Chem.
261
15062-15069
1986
Escherichia coli
brenda
Schaap, D.; de Widt, J.; van der Wal, J.; Vandekerckhove, J.; van Damme, J.; Gussow, D.; Ploegh, H.L.; van Blitterswijk, W.J.; van der Bend, R.L.
Purification, cDNA-cloning and expression of human diacylglycerol kinase
FEBS Lett.
275
151-158
1990
Escherichia coli, Homo sapiens
brenda
Russ, E.; Kaiser, U.; Sandermann, H.
Lipid-dependent membrane enzymes. Purification to homogeneity and further characterization of diacylglycerol kinase from Escherichia coli
Eur. J. Biochem.
171
335-342
1988
Escherichia coli
brenda
Bohnenberger, E.; Sandermann, H.
Lipid dependence of diacylglycerol kinase from Escherichia coli
Eur. J. Biochem.
132
645-650
1983
Escherichia coli
brenda
Bohnenberger, E.; Sandermann, H.
Diglyceride kinase from Escherichia coli. Purification in organic solvent and some properties of the enzyme
Eur. J. Biochem.
94
401-407
1979
Escherichia coli
brenda
Loomis, C.R.; Walsh, J.P.; Bell, R.M.
sn-1,2-Diacylglycerol kinase of Escherichia coli. Purification, reconstitution, and partial amino- and carboxyl-terminal analysis
J. Biol. Chem.
260
4091-4097
1985
Escherichia coli
brenda
Lau, F.W.; Chen, X.; Bowie, J.U.
Active sites of diacylglycerol kinase from Escherichia coli are shared between subunits
Biochemistry
38
5521-5527
1999
Escherichia coli
brenda
Badola, P.; Sanders, C.R.2nd.
Escherichia coli diacylglycerol kinase is an evolutionarily optimized membrane enzyme and catalyzes direct phosphoryl transfer
J. Biol. Chem.
272
24176-24182
1997
Escherichia coli
brenda
Clark, E.H.; East, J.M.; Lee, A.G.
The role of tryptophan residues in an integral membrane protein: diacylglycerol kinase
Biochemistry
42
11065-11073
2003
Escherichia coli
brenda
Bakali, M.A.; Nordlund, P.; Hallberg, B.M.
Expression, purification, crystallization and preliminary diffraction studies of the mammalian DAG kinase homologue YegS from Escherichia coli
Acta Crystallogr. Sect. F
62
295-297
2006
Escherichia coli
brenda
Mi, D.; Kim, H.J.; Hadziselimovic, A.; Sanders, C.R.
Irreversible misfolding of diacylglycerol kinase is independent of aggregation and occurs prior to trimerization and membrane association
Biochemistry
45
10072-10084
2006
Escherichia coli
brenda
Jittikoon, J.; East, J.M.; Lee, A.G.
A fluorescence method to define transmembrane alpha-helices in membrane proteins: studies with bacterial diacylglycerol kinase
Biochemistry
46
10950-10959
2007
Escherichia coli
brenda
Van Horn, W.; Kim, H.; Ellis, C.; Hadziselimovic, A.; Sulistijo, E.; Karra, M.; Tian, C.; Soennichsen, F.; Sanders, C.
Solution nuclear magnetic resonance structure of membrane-integral diacylglycerol kinase
Science
324
1726-1729
2009
Escherichia coli (P0ABN1), Escherichia coli
brenda
Li, D.; Stansfeld, P.J.; Sansom, M.S.; Keogh, A.; Vogeley, L.; Howe, N.; Lyons, J.A.; Aragao, D.; Fromme, P.; Fromme, R.; Basu, S.; Grotjohann, I.; Kupitz, C.; Rendek, K.; Weierstall, U.; Zatsepin, N.A.; Cherezov, V.; Liu, W.; Bandaru, S.; English, N.J.; Gati, C.; Barty, A.; Yefanov, O.; Chapman, H.N.; Diederichs, K.; Messerschmidt, M.; Boutet, S.; Williams, G.J.; Seibert, M.M.; Caffrey, M.
Ternary structure reveals mechanism of a membrane diacylglycerol kinase
Nat. Commun.
6
10140
2015
Escherichia coli (P0ABN1), Escherichia coli
brenda
Li, D.; Lyons, J.A.; Pye, V.E.; Vogeley, L.; Aragao, D.; Kenyon, C.P.; Shah, S.T.; Doherty, C.; Aherne, M.; Caffrey, M.
Crystal structure of the integral membrane diacylglycerol kinase
Nature
497
521-524
2013
Escherichia coli (P0ABN1)
brenda
Jiang, Y.; Tan, H.; Zheng, J.; Li, X.; Chen, G.; Jia, Z.
Phosphoryl transfer reaction catalyzed by membrane diacylglycerol kinase: a theoretical mechanism study
Phys. Chem. Chem. Phys.
17
25228-25234
2015
Escherichia coli (P0ABN1)
brenda